Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia
Zhu et al., BMC Cancer, doi:10.1186/s12885-026-15553-x
https://c19early.org/zhu14.html